ERBB2 and breast carcinoma: Monocyte_1_IL1B exhibited a strong correlation with mechanistically related pathways, such as the ERBB2 − EGFR signaling pathway, which has been reported to promote the proliferation and migration of breast cancer cells [45] (Fig. 7G).